The company said, "OptimizeRx is providing revenue guidance for its fiscal first quarter ending March 31, 2023 and is looking for revenue to come in between $11.5 million and $13 million."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OPRX:
- OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
- OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
- OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
- OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
- OptimizeRx resumed with a Buy at B. Riley